ReviewJournal of clinical medicine2023

Biomarkers for Assessing Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus on Sodium-Glucose Cotransporter 2 Inhibitor Therapy.

Farah Khaznadar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.